ArticleInfectious diseases and therapy2022

Effectiveness of Subcutaneous Casirivimab and Imdevimab in Ambulatory Patients with COVID-19.

Jessica J Jalbert et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.